Cite
HARVARD Citation
Avallone, A. et al. (n.d.). P-263Survival analysis of a multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC). Annals of oncology. p. . [Online].